Samuel Oudkerk
CFO and Member of the Board at LinXis Biopharmaceuticals at LinXis Biopharmaceuticals- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
LinXis Biopharmaceuticals
-
Netherlands
-
Biotechnology Research
-
1 - 100 Employee
-
CFO and Member of the Board at LinXis Biopharmaceuticals
-
Jan 2019 - Present
LinXis is the world's first and only Fibrobody®-drug-conjugate company. We unlock the potential of powerful molecules by building them into smart, targeted medicines to cure patients with fibrotic diseases LinXis is the world's first and only Fibrobody®-drug-conjugate company. We unlock the potential of powerful molecules by building them into smart, targeted medicines to cure patients with fibrotic diseases
-
-
-
Surmount Ventures
-
Netherlands
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Managing Partner and Founder
-
Jan 2014 - Jan 2019
Our Venture Capital Fund holds investments in: LinXis Biopharmaceuticals - AHV Animal Health - HHV Biotech - QHV Qleaning Hygiene - CHV Crop Health - IncluSIF - Valeo Clinics - Moving Intelligence - Medical One Solutions Our Venture Capital Fund holds investments in: LinXis Biopharmaceuticals - AHV Animal Health - HHV Biotech - QHV Qleaning Hygiene - CHV Crop Health - IncluSIF - Valeo Clinics - Moving Intelligence - Medical One Solutions
-
-
-
Deloitte
-
Business Consulting and Services
-
700 & Above Employee
-
Co-Founder and Director Deloitte LifeTrack
-
2011 - 2014
Unique match making program for early stage companies and big pharma in the Lifescience & Healthcare sector
-
-
Manager - Lifesciences & Healthcare
-
2006 - 2011
-
-
-
YTEC
-
Netherlands
-
IT Services and IT Consulting
-
1 - 100 Employee
-
Investor & Co-Founder
-
2008 - 2012
-
-
-
KPMG Nederland
-
Netherlands
-
Financial Services
-
700 & Above Employee
-
Reseacher /Jr. Consultant
-
2005 - 2006
-
-